title: Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.
authors.forename: Hussam
authors.initials: H
authors.lastname: Ammar
authors.forename: Ashok K
authors.initials: AK
authors.lastname: Malani
authors.forename: Chakshu
authors.initials: C
authors.lastname: Gupta
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood / Q000187:drug effects; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents; D018120:Finasteride; D017430:Prostate-Specific Antigen